DSM Managing Board Change

Royal DSM, a global science-based company active in health, nutrition and materials, today announces the departure of Managing Board and Executive Committee member Stephan B. Tanda per 1 February 2017. Stephan joined DSM on 1 March 2007 and became a member of the Managing Board on 1 May 2007. Within DSM, Stephan is currently responsible for DSM’s Nutrition cluster, oversees DSM’s operations and responsible care function as well as the activities in North- and South-America and is a Board member of DSM’s pharma joint ventures (Patheon and DSM Sinochem Pharmaceuticals).

As of 1 February 2017 Stephan will be appointed as President and CEO of the AptarGroup, Inc. [NYSE: ATR], a global leader in innovative dispensing and sealing solutions. The AptarGroup is based in the USA and reported about EUR2 billion sales over 2015. The responsibilities of Stephan Tanda will be re-arranged among the Managing Board and Executive Committee members. Feike Sijbesma, CEO and Chairman of the DSM Managing Board, commented: “During the years that Stephan worked for DSM he has been instrumental in creating our unique, broad and global Nutrition business from which to build further. We are very grateful for the contributions he has made to the transformation of our company. We respect Stephan’s decision to seize this opportunity and to return to the US. Also on behalf of my colleagues, I wish him every success in this next step of his career. In the coming period we will consider how to re-arrange the responsibilities of Stephan Tanda.” DSM – Bright Science. Brighter Living.(TM) Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about EUR10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com. Forward-looking statements This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.